In experiments EPL001 inhibits the proliferation in vitro of MCF7 breast cancer cells stimulated by IGF1 and causes a dose-dependent reduction in LH secretion by ovine pituitary cells in vitro and likewise reduces prolactin production (Hart, 2013). Here, IGF1 is linked to breast cancer.